C

Concert Pharmaceuticals Inc
F:73C

Watchlist Manager
Concert Pharmaceuticals Inc
F:73C
Watchlist
Price: 7.818 EUR Market Closed
Market Cap: 374.8m EUR

Relative Value

There is not enough data to reliably calculate the relative value of 73C.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

73C Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
9 674.4
Median 5Y
9 433
Industry
7.9
Forward
118.1
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.5
Industry
23.7
Forward
-3
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-3.7
Industry
22
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-3.6
Industry
24.3
vs History
vs Industry
Median 3Y
3.1
Median 5Y
3
Industry
3.3
vs History
vs Industry
Median 3Y
6 114.1
Median 5Y
5 872.7
Industry
8.2
Forward
78.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.2
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
6.1
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
6.5
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
7.9
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
6.3
vs History
vs Industry
Median 3Y
13.6
Median 5Y
13.1
Industry
5.7

Multiples Across Competitors

73C Competitors Multiples
Concert Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Concert Pharmaceuticals Inc
F:73C
374.8m EUR 10 485 -2.7 -1.8 -1.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 766 261.7 -160 486 -194 881.2 -192 657.4
US
Abbvie Inc
NYSE:ABBV
406B USD 6.8 172.9 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
176.8B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
153B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 9.8 31.4 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.4 -532.4 -579.7 -564.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.4B USD 5.7 17.8 17 19.2
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.2B USD 16.3 1 197.7 161.5 195.9
NL
argenx SE
XBRU:ARGX
43.6B EUR 14.2 33.4 57.5 59.1
P/E Multiple
Earnings Growth PEG
US
C
Concert Pharmaceuticals Inc
F:73C
Average P/E: 189.5
Negative Multiple: -2.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 486 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.9
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 197.7
N/A N/A
NL
argenx SE
XBRU:ARGX
33.4
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Concert Pharmaceuticals Inc
F:73C
Average EV/EBITDA: 39.9
Negative Multiple: -1.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 881.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
161.5
N/A N/A
NL
argenx SE
XBRU:ARGX
57.5
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Concert Pharmaceuticals Inc
F:73C
Average EV/EBIT: 46.1
Negative Multiple: -1.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 657.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
195.9
N/A N/A
NL
argenx SE
XBRU:ARGX
59.1
N/A N/A